<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38719316</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>07</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Predictors of somatic symptoms during the COVID-19 pandemic: a national longitudinal survey in Japan.</ArticleTitle><Pagination><StartPage>e082439</StartPage><MedlinePgn>e082439</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e082439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2023-082439</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The COVID-19 pandemic has highlighted the long-term consequences of SARS-CoV-2 infection, termed long COVID. However, in the absence of comparative groups, the differentiation of disease progression remains difficult, as COVID-19 symptoms become indistinguishable from symptoms originating from alternative etiologies. This study aimed to longitudinally investigate the association between COVID-19 exposure and the somatic symptoms in the Japanese general population.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This was a longitudinal cohort study with 1-year follow-up.</AbstractText><AbstractText Label="SETTING AND PARTICIPANTS" NlmCategory="METHODS">Longitudinal data from 19&#x2009;545 individuals who participated in the Japan Society and New Tobacco Internet Survey (JASTIS) 2022 and 2023 were included. In this study, we used data from the 2022 JASTIS as baseline data and the 2023 JASTIS as follow-up data. Based on questionnaire responses, respondents were classified into three categories of exposure to COVID-19.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">The somatic symptoms were assessed by the Somatic Symptom Scale-8 (SSS-8). Using generalised linear models adjusted for baseline covariates, we calculated the ORs of having very high somatic symptoms assessed by SSS-8, attributable to COVID-19 exposure (no COVID-19 cases as the reference group).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Follow-up completers were divided into three groups according to COVID-19 exposure (no COVID-19, n=16&#x2009;012; COVID-19 without O2 therapy, n=3201; COVID-19 with O<sub>2</sub> therapy, n=332). After adjusting for all covariates, COVID-19 cases with O<sub>2</sub> therapy had a significant positive association (OR 7.60, 95%&#x2009;CI 5.47 to 10.58) with a very high somatic symptoms burden while other COVID-19 exposure groups did not. Pre-existing physical and psychological conditions were also associated with increased risk of somatic symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The findings of our study suggest that the severity of COVID-19 symptoms requiring O<sub>2</sub> therapy in the acute phase led to high somatic symptoms. Pre-existing conditions were also associated with a subsequent risk of somatic symptoms.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sugawara</LastName><ForeName>Norio</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7058-664X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Dokkyo Medical University, Shimotsuga-gun, Tochigi, Japan nsuga3@dokkyomed.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabuchi</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1050-3125</Identifier><AffiliationInfo><Affiliation>Osaka International Cancer Institute, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumitsu</LastName><ForeName>Keita</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6747-4348</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Dokkyo Medical University, Shimotsuga-gun, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasui-Furukori</LastName><ForeName>Norio</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4414-3770</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Dokkyo Medical University, Shimotsuga-gun, Tochigi, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071896" MajorTopicYN="Y">Medically Unexplained Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EPIDEMIOLOGY</Keyword><Keyword MajorTopicYN="N">Public health</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>9</Day><Hour>0</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>9</Day><Hour>0</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38719316</ArticleId><ArticleId IdType="pmc">PMC11086443</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2023-082439</ArticleId><ArticleId IdType="pii">bmjopen-2023-082439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO . WHO coronavirus (COVID-19) dashboard, 2023. Available: https://covid19.who.int/ [Accessed 1 Sep 2023].</Citation></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061&#x2013;9. 10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Maddukuri G, et al. . Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with COVID-19 and seasonal influenza: cohort study. BMJ 2020;371:m4677. 10.1136/bmj.m4677</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4677</ArticleId><ArticleId IdType="pmc">PMC7735416</ArticleId><ArticleId IdType="pubmed">33323357</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom EF, Nath A, Power C, et al. . Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain 2021;144:3576&#x2013;88. 10.1093/brain/awab302</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S, Zhao Y, Zeng N, et al. . Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Mol Psychiatry 2023;28:4056&#x2013;69. 10.1038/s41380-023-02171-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . A clinical case definition of post COVID-19 condition by a Delphi consensus, 2021. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed 1 Sep 2023].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao Y-M, Yan W, et al. . A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry 2023;28:423&#x2013;33. 10.1038/s41380-022-01614-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022;328:1604. 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun 2022;13:3528. 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022;28:1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Ailshire JA, Crimmins EM. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci Rep 2022;12:11647. 10.1038/s41598-022-15727-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15727-0</ArticleId><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi T, Shinozaki T, Kunugita N, et al. . Study profile: the Japan &#x2018;society and new tobacco&#x2019; Internet survey (JASTIS): a longitudinal internet cohort study of heat-not-burn tobacco products, electronic cigarettes, and conventional tobacco products in Japan. J Epidemiol 2019;29:444&#x2013;50. 10.2188/jea.JE20180116</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20180116</ArticleId><ArticleId IdType="pmc">PMC6776477</ArticleId><ArticleId IdType="pubmed">30318495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamata K, Honda H, Tokuda Y, et al. . Post-COVID health-related quality of life and somatic symptoms: a national survey in Japan. Am J Med Sci 2023;366:114&#x2013;23. 10.1016/j.amjms.2023.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2023.04.018</ArticleId><ArticleId IdType="pmc">PMC10140465</ArticleId><ArticleId IdType="pubmed">37120076</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama Y, Tabuchi T. Stepwise tobacco price increase and smoking behavioral changes in Japan: the Japan &#x2018;society and new tobacco&#x2019; Internet survey 2017-2021 longitudinal study. Nicotine Tob Res 2023;25:657&#x2013;64. 10.1093/ntr/ntac254</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntac254</ArticleId><ArticleId IdType="pubmed">36331077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gierk B, Kohlmann S, Kroenke K, et al. . The somatic symptom Scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med 2014;174:399&#x2013;407. 10.1001/jamainternmed.2013.12179</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2013.12179</ArticleId><ArticleId IdType="pubmed">24276929</ArticleId></ArticleIdList></Reference><Reference><Citation>Midorikawa H, Tachikawa H, Aiba M, et al. . Proposed cut-off score for the Japanese version of the fear of Coronavirus disease 2019 scale (FCV-19S): evidence from a large-scale national survey in Japan. Int J Environ Res Public Health 2022;20:429. 10.3390/ijerph20010429</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010429</ArticleId><ArticleId IdType="pmc">PMC9819218</ArticleId><ArticleId IdType="pubmed">36612751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai K, Nishi A, Kondo K, et al. . Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan. Psychiatry Clin Neurosci 2011;65:434&#x2013;41. 10.1111/j.1440-1819.2011.02236.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1819.2011.02236.x</ArticleId><ArticleId IdType="pubmed">21851452</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi T, Fujiwara T, Shinozaki T. Tobacco price increase and smoking behaviour changes in various subgroups: a nationwide longitudinal 7-year follow-up study among a middle-aged Japanese population. Tob Control 2017;26:69&#x2013;77. 10.1136/tobaccocontrol-2015-052804</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tobaccocontrol-2015-052804</ArticleId><ArticleId IdType="pmc">PMC5256309</ArticleId><ArticleId IdType="pubmed">26880743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakaizumi K, Yamada K, Shimazu A, et al. . Sitting for long periods is associated with impaired work performance during the COVID-19 pandemic. J Occup Health 2021;63:e12258. 10.1002/1348-9585.12258</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1348-9585.12258</ArticleId><ArticleId IdType="pmc">PMC8333769</ArticleId><ArticleId IdType="pubmed">34346132</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang C, Morita S, Hirakawa Y, et al. . Possible contribution of COVID-19 vaccination to the subsequent mental well-being in Japan. Sci Rep 2022;12:21195. 10.1038/s41598-022-25357-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25357-1</ArticleId><ArticleId IdType="pmc">PMC9729563</ArticleId><ArticleId IdType="pubmed">36477701</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods 2002;7:147&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">12090408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2081237</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021;27:1507&#x2013;13. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilunga FP, Appelman B, van Vugt M, et al. . Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study. Lancet Reg Health Eur 2023;29:100630. 10.1016/j.lanepe.2023.100630</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100630</ArticleId><ArticleId IdType="pmc">PMC10079482</ArticleId><ArticleId IdType="pubmed">37261215</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, et al. . Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine 2023;41:1783&#x2013;90. 10.1016/j.vaccine.2023.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. . Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry 2022;79:1081&#x2013;91. 10.1001/jamapsychiatry.2022.2640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahk W-M, Park S, Jon D-I, et al. . Relationship between painful physical symptoms and severity of depressive symptomatology and suicidality. Psychiatry Res 2011;189:357&#x2013;61. 10.1016/j.psychres.2011.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2011.01.009</ArticleId><ArticleId IdType="pubmed">21329990</ArticleId></ArticleIdList></Reference><Reference><Citation>Creed FH, Davies I, Jackson J, et al. . The epidemiology of multiple somatic symptoms. J Psychosom Res 2012;72:311&#x2013;7. 10.1016/j.jpsychores.2012.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2012.01.009</ArticleId><ArticleId IdType="pubmed">22405227</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller O, Chun Y, Shapira S, et al. . Prevalence of long-COVID among low-income and marginalized groups: evidence from Israel. Int J Public Health 2022;67:1605086. 10.3389/ijph.2022.1605086</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2022.1605086</ArticleId><ArticleId IdType="pmc">PMC9742204</ArticleId><ArticleId IdType="pubmed">36518871</ArticleId></ArticleIdList></Reference><Reference><Citation>Qasmieh SA, Robertson MM, Teasdale CA, et al. . The prevalence of SARS-Cov-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022. Prev Med 2023;169:107461. 10.1016/j.ypmed.2023.107461</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2023.107461</ArticleId><ArticleId IdType="pmc">PMC9940463</ArticleId><ArticleId IdType="pubmed">36813250</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>